Edition:
United States

Aytu BioScience Inc (AYTU.OQ)

AYTU.OQ on NASDAQ Stock Exchange Capital Market

0.57USD
23 Apr 2018
Change (% chg)

$-0.02 (-2.87%)
Prev Close
$0.59
Open
$0.59
Day's High
$0.60
Day's Low
$0.55
Volume
265,966
Avg. Vol
392,192
52-wk High
$6.35
52-wk Low
$0.38

Select another date:

Thu, Mar 8 2018

BRIEF-Bigger Capital Fund Reports 7.4 Pct Passive Stake In Aytu Bioscience As Of March 2

* BIGGER CAPITAL FUND L P REPORTS A 7.4 PERCENT PASSIVE STAKE IN AYTU BIOSCIENCE INC AS OF MARCH 2 - SEC FILING Source text: (http://bit.ly/2HiWvi8) Further company coverage:

BRIEF-Aytu Bioscience Gets Market Registration For The Mioxsys System For Male Infertility In Mexico

* AYTU BIOSCIENCE RECEIVES MARKET REGISTRATION FOR THE MIOXSYS® SYSTEM FOR MALE INFERTILITY IN MEXICO Source text for Eikon: Further company coverage:

BRIEF-Aytu Bioscience Announces Pricing Of $12 Mln Public Offering

* AYTU BIOSCIENCE ANNOUNCES PRICING OF $12,000,000 PUBLIC OFFERING

BRIEF-Aytu BioScience Provides Update On The Continued Growth Of Natesto In The U.S.

* AYTU BIOSCIENCE PROVIDES UPDATE ON THE CONTINUED GROWTH OF NATESTO® IN THE U.S. Source text for Eikon: Further company coverage:

BRIEF-Aytu Bioscience Q2 Revenue $1.1 Mln, An Increase Of 32 pct

* AYTU BIOSCIENCE INC - TOTAL REVENUE FOR Q2 WAS ABOUT $1.1 MILLION, AN INCREASE OF 32%

BRIEF-Aytu Bioscience Appoints David Green As CFO

* AYTU BIOSCIENCE ANNOUNCES APPOINTMENT OF DAVID GREEN AS CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-Aytu Bioscience files for mixed shelf of upto $100 mln

* Aytu Bioscience Inc files for mixed shelf of upto $100 million - SEC Filing Source text: [http://bit.ly/2B3AW23] Further company coverage:

BRIEF-Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system

* Aytu Bioscience receives market approval from the Australian therapeutic goods administration for the Mioxsys® system for male infertility

BRIEF-Aytu Bioscience CFO Gregory Gould resigns

* Aytu Bioscience Inc - ‍on October 26, 2017, Gregory A. Gould resigned as Chief Financial Officer​

Select another date: